StockData
Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc. (ORMP) stock

ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.87−0.03 (-0.77%)

Close on Nov 17, 2026Market cap $160.98MP/E 0.9Yield 6.46%

Oramed Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

Oramed Pharmaceuticals's R&D Expenses for the twelve months ending Jun 30, 2026 was $4.74M, down 31.8% year over year. For fiscal 2025 it was $6.38M, up 0.9% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $20.99M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.38M+0.9%
FY2024Dec 31, 2024$6.32M-29.5%
FY2023Dec 31, 2023$8.97M-57.3%
FY2021Aug 31, 2021$20.99M+105.1%
FY2020Aug 31, 2020$10.24M-24.3%
FY2019Aug 31, 2019$13.52M+12.9%
FY2018Aug 31, 2018$11.98M+16.5%
FY2017Aug 31, 2017$10.28M+33.4%
FY2016Aug 31, 2016$7.71M+61.2%
FY2015Aug 31, 2015$4.78M+45.9%
FY2014Aug 31, 2014$3.28M–
FY2013Aug 31, 2013-$2.27M-235.2%
FY2012Aug 31, 2012$1.68M+45.0%
FY2011Aug 31, 2011$1.16M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$0-100.0%
Q1 FY2026CQ1 2026Mar 31, 2026$1.59M-27.7%
Q4 FY2025CQ4 2025Dec 31, 2025$1.99M+36.1%
Q3 FY2025CQ3 2025Sep 30, 2025$1.15M-48.6%
Q2 FY2025CQ2 2025Jun 30, 2025$1.03M-28.3%
Q1 FY2025CQ1 2025Mar 31, 2025$2.21M+87.1%
Q4 FY2024CQ4 2024Dec 31, 2024$1.46M-17.3%
Q3 FY2024CQ3 2024Sep 30, 2024$2.24M+134.3%
Q2 FY2024CQ2 2024Jun 30, 2024$1.44M-20.8%
Q1 FY2024CQ1 2024Mar 31, 2024$1.18M-73.4%
Q4 FY2023CQ4 2023Dec 31, 2023$1.77M-69.8%
Q3 FY2023CQ3 2023Sep 30, 2023$957.00K-82.6%
Q2 FY2023CQ2 2023Jun 30, 2023$1.82M-52.9%
Q1 FY2023CQ1 2023Mar 31, 2023$4.43M-23.3%
Q4 FY2021CQ3 2021Aug 31, 2021$5.84M+96.9%
Q3 FY2021CQ2 2021May 31, 2021$5.50M+185.8%
Q2 FY2021CQ1 2021Feb 28, 2021$3.87M+16.5%
Q1 FY2021CQ4 2020Nov 30, 2020$5.77M+185.6%
Q4 FY2020CQ3 2020Aug 31, 2020$2.97M+34.9%
Q3 FY2020CQ2 2020May 31, 2020$1.93M-50.1%
Q2 FY2020CQ1 2020Feb 29, 2020$3.32M+21.4%
Q1 FY2020CQ4 2019Nov 30, 2019$2.02M-51.8%
Q4 FY2019CQ3 2019Aug 31, 2019$2.20M-19.2%
Q3 FY2019CQ2 2019May 31, 2019$3.86M+65.9%
Q4 FY2018CQ3 2018Aug 31, 2018$2.73M+7.8%
Q3 FY2018CQ2 2018May 31, 2018$4.19M+85.0%
Q2 FY2018CQ1 2018Feb 28, 2018$2.72M-12.8%
Q1 FY2018CQ4 2017Nov 30, 2017$2.33M-1.1%
Q4 FY2017CQ3 2017Aug 31, 2017$2.54M-79.9%
Q3 FY2017CQ2 2017May 31, 2017$2.27M–
Q2 FY2017CQ1 2017Feb 28, 2017$3.13M+139.8%
Q1 FY2017CQ4 2016Nov 30, 2016$2.35M–
Q4 FY2016CQ3 2016Aug 31, 2016$12.62M+784.0%
Q3 FY2016CQ2 2016May 31, 2016-$1.71M-286.9%
Q2 FY2016CQ1 2016Feb 29, 2016$1.30M+14.7%
Q1 FY2016CQ4 2015Nov 30, 2015-$1.90M–
Q4 FY2015CQ3 2015Aug 31, 2015$1.43M–
Q3 FY2015CQ2 2015May 31, 2015$915.00K–
Q2 FY2015CQ1 2015Feb 28, 2015$1.14M–

More Oramed Pharmaceuticals figures

See a number that looks wrong?